TrialHuman vaccines & immunotherapeutics2022

Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial.

Ahmet Omma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.